FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2053151 · Received April 13, 2011

Report

Report Number
2124215-2011-05489
Event Type
Injury
Date Received
April 13, 2011
Date of Event
March 22, 2011
Report Date
March 3, 2011
Manufacturer
GUIDANT PUERTO RICO BV
Product Code
NVY
PMA / PMN Number
P910073
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION VIA THEIR LITERATURE REVIEW PROCESS, THAT THESE TWO RIGHT VENTRICULAR LEADS EXHIBITED SENSING ISSUES AND ULTIMATELY NEEDED TO BE REPLACED. DURING THE EXTRACTION PROCESS OF THE FINELINE II PRODUCT, THE LEAD MANIFESTED AN APPARENT FRACTURE. NO FURTHER DETAILS ON THE ENDOTAK RELIANCE LEAD PROVIDED WITHIN THE CONTEXT OF THE ARTICLE; HOWEVER, IT WAS MENTIONED THE LEAD WAS REMOVED FOR A SIMILAR ANOMALY. THE AUTHOR OF THE PUBLICATION WAS CONTACTED HOWEVER, UNABLE TO PROVIDE THE ASSOCIATED SERIAL NUMBERS OF THE LEADS, SO AS TO CROSS REFERENCE OUR INTERNAL COMPLAINT HANDLING SYSTEM FOR PREVIOUSLY ENTERED INFORMATION. WHILE NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED, THE LEAD WAS REMOVED VIA THE FEMORAL APPROACH WITH A LASER TECHNIQUE, AS WAS THE DISCUSSION OF THIS PUBLICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY GUIDANT PUERTO RICO BV 0175

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention